Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease

被引：0
|
作者：
Marcel N Menke
Carsten Framme
Mathias Nelle
Markus R Berger
Veit Sturm
Sebastian Wolf
机构：
[1] Bern University Hospital,Department of Ophthalmology, Inselspital
[2] and University of Bern,University Eye Hospital
[3] Medical School Hannover,Department of Neonatology, Inselspital
[4] Bern University Hospital,Department of Ophthalmology
[5] and University of Bern,Department of Ophthalmology
[6] Cantonal Hospital St. Gallen,undefined
[7] Cantonal Hospital Aarau,undefined
来源：
BMC Ophthalmology | / 15卷
关键词：
Retinopathy of prematurity; Ranibizumab; Bevacizumab; Plus disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Risk of recurrence of retinopathy of prematurity after initial intravitreal ranibizumab therapy
    Chan, Joyce J. T.
    Lam, Carol P. S.
    Kwok, Madeline K. M.
    Wong, Raymond L. M.
    Lee, Gary K. Y.
    Lau, Winnie W. Y.
    Yam, Jason C. S.
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [42] Active Iris in Retinopathy of Prematurity and Regression Following Intravitreal Ranibizumab Injection
    Lu, Fang
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2018, 49 (08): : 643 - 644
  • [43] Evaluation of retinal vascularization in retinopathy of prematurity regressed after intravitreal ranibizumab monotherapy or without treatment based on fluorescein angiography
    Wu, Lei
    Li, Manhong
    Wang, Liang
    Yan, Hongxiang
    Zhou, Ziyi
    Fan, Jing
    Zhou, Yi
    Gou, Kaili
    Guo, Changmei
    Wang, Yusheng
    Zhang, Zifeng
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01):
  • [44] Vitreous Syneresis after Intravitreal Injection of Ranibizumab in Treatment of Retinopathy of Prematurity
    Akkoyun, Imren
    Karadas, Mustafa
    Yilmaz, Gursel
    Tugcu, A. Ulas
    Kayhan, Zeynep
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : E159 - E160
  • [45] Risk of recurrence of retinopathy of prematurity after initial intravitreal ranibizumab therapy
    Joyce J. T. Chan
    Carol P. S. Lam
    Madeline K. M. Kwok
    Raymond L. M. Wong
    Gary K. Y. Lee
    Winnie W. Y. Lau
    Jason C. S. Yam
    [J]. Scientific Reports, 6
  • [46] Efficacy evaluation of intravitreal ranibizumab therapy for three types of retinopathy of prematurity
    Qiong Zou
    Yan-Qiong Zhu
    Feng-Jun Zhang
    Qiu-Ping Liu
    [J]. International Journal of Ophthalmology, 2022, (05) : 753 - 759
  • [47] Comparative Analysis of Intravitreal Ranibizumab versus Laser Therapy for Retinopathy of Prematurity
    Elabbasy, Ahmed
    Abdelbaky, Mona
    Al-Shehri, Hassan
    Padua, Ilene
    Hamed, Ahmed
    Kashlan, Aladdin
    Alrobaie, Abdullah
    Albarqi, Abdulrahman
    Aldawalibi, Ammar
    Ammari, Amer
    Kashlan, Fawaz
    [J]. ARCHIVES OF PHARMACY PRACTICE, 2022, 13 (02) : 30 - 36
  • [48] Combination of Intravitreal Ranibizumab and Laser Photocoagulation for Aggressive Posterior Retinopathy of Prematurity
    Mota, Agata
    Carneiro, Angela
    Breda, Jorge
    Rosas, Vitor
    Magalhaes, Augusto
    Silva, Renato
    Falcao-Reis, Fernando
    [J]. CASE REPORTS IN OPHTHALMOLOGY, 2012, 3 (01): : 136 - 141
  • [49] Comparison of clinical outcomes of intravitreal ranibizumab and aflibercept treatment for retinopathy of prematurity
    Sukgen, Emine Alyamac
    Kocluk, Yusuf
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (01) : 49 - 55
  • [50] Efficacy evaluation of intravitreal ranibizumab therapy for three types of retinopathy of prematurity
    Zou, Qiong
    Zhu, Yan-Qiong
    Zhang, Feng-Jun
    Liu, Qiu-Ping
    [J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2022, 15 (05) : 753 - 759
12345